Geode Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $237K | Buy |
348,825
+2,849
| +0.8% | +$1.93K | ﹤0.01% | 3821 |
|
2025
Q1 | $294K | Buy |
345,976
+34,317
| +11% | +$29.2K | ﹤0.01% | 3728 |
|
2024
Q4 | $257K | Buy |
311,659
+27,804
| +10% | +$23K | ﹤0.01% | 3816 |
|
2024
Q3 | $281K | Buy |
283,855
+24,972
| +10% | +$24.7K | ﹤0.01% | 3790 |
|
2024
Q2 | $207K | Buy |
258,883
+36,934
| +17% | +$29.6K | ﹤0.01% | 3894 |
|
2024
Q1 | $266K | Buy |
221,949
+24,828
| +13% | +$29.8K | ﹤0.01% | 3840 |
|
2023
Q4 | $312K | Buy |
197,121
+18,859
| +11% | +$29.8K | ﹤0.01% | 3788 |
|
2023
Q3 | $159K | Buy |
178,262
+49,366
| +38% | +$44K | ﹤0.01% | 4069 |
|
2023
Q2 | $155K | Buy |
128,896
+14,647
| +13% | +$17.6K | ﹤0.01% | 4160 |
|
2023
Q1 | $184K | Hold |
114,249
| – | – | ﹤0.01% | 4093 |
|
2022
Q4 | $137K | Sell |
114,249
-314
| -0.3% | -$377 | ﹤0.01% | 4276 |
|
2022
Q3 | $193K | Buy |
114,563
+65,847
| +135% | +$111K | ﹤0.01% | 4236 |
|
2022
Q2 | $39K | Buy |
48,716
+11,471
| +31% | +$9.18K | ﹤0.01% | 4824 |
|
2022
Q1 | $40K | Buy |
+37,245
| New | +$40K | ﹤0.01% | 4847 |
|